Sebana Medical specializes in the development, manufacturing, and commercialization of cutting-edge products utilizing a proprietary platform SEBA. Its advanced Biologic Matrix Slow-Release Technology revolutionizes the delivery of a therapeutic solution, ensuring optimal efficacy and long-lasting effects of autologous fat grafts.
SEBA is indicated for treating fat grafts for dermal filling. Sebana Medical ambition is to prove the efficacy and commercialize SEBA for dermal filling with autologous fat.
Sebana Medical has successfully demonstrated the safety and efficacy of SEBA in rigorous preclinical studies, paving the way for its transition to clinical trials. By harnessing the power of advanced drug slow-release polymer technology, scientific expertise, and development, it has achieved a breakthrough innovation that holds immense potential.
Its technology prevents fat resorption in soft tissue augmentation and extends to various cosmetic indications.